Trino Baptista, Mariano Motuca, Ana Serrano, Alirio Perez Lo Presti, Alberto Fernandez-Arana, Ismael Olmos, Albis Pabon, Juan Genaro Ayala Yepez, Gabriel de Jesus Alejo Galarza, Nuria Monserrat Rivera Ramirez, Helio Elkis, Emilio J Sanz, Carlos De Las Cuevas, Jose de Leon
There is growing interest in clozapine clinical use, monitoring, and research, particularly adverse drug reactions (ADRs) other than agranulocytosis. In this study we focused on clozapine pharmacovigilance. Hence, we contacted clinicians and researchers in Latin America and requested information about local psychiatric services, clozapine availability, clinical use, and ADR monitoring with the VigiBase system. Only two countries have the minimum recommended number of psychiatric beds (15 per 100,000 residents): Uruguay (N = 34...
November 18, 2023: Schizophrenia Research